28
FEB
Reports
Q4, 2023 earnings report expected
CLDX
Celldex Therapeutics Inc
0
0
(0%)
EPS
$-0.713333
Estimated Sales
$915.75K
Market Cap
$2.06B
Trade
Mentioned
CLDX
-3.58 (-10.53%)
S
30.33
B
30.46
@MarketUpdates
United Kingdom10 months ago
28
FEB
Reports
Q4, 2023 earnings report expected
CLDX
Celldex Therapeutics Inc
0
0
(0%)
EPS
$-0.713333
Estimated Sales
$915.75K
Market Cap
$2.06B
Trade
1 Mentioned
CLDX
Celldex Therapeutics Inc